(10)
[8] Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. The Lancet Respiratory Medicine, 2020;8(12):1233-1244.
[9] Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and
IL-10 are disease severity predictors. Emerging Microbes and Infections, 2020;9(1):1123-1130.
[10] Lu L, Zhang H, Dauphars DJ, et al. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis. Trends in Immunology, 2021;42(1):3-5.
[11] Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of. severe fever with thrombocytopenia syndrome. Journal of Infectious Diseases, 2012;206(7): 1085-1094.
[12] Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity, 2008;28(4): 468-476.
[13] Ferreira-Gomes M, Kruglov A, Durek P, et al. SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself. Nature Communication, 2021;30; 12(1).
[14] Deng B, Zhang S, Geng Y, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One, 2012;7(7):e41365.
[15] Yang T, Huang H, Jiang L, et al. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review). Internal Journal of Molecular Medicine, 2022;50(3):118.
[16] Yun Y, Heo ST, Kim G, et al. Phylogenetic Analysis of Severe Fever with Thrombocytopenia Syndrome Virus in South Korea and Migratory Bird Routes Between China, South Korea, and Japan. American Journal of Tropical Medicine and Hygiene, 2015;93(3):468-74.
[17] Kang JG, Jeon K, Choi H, et al. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice. PLoS Neglected Tropical Diseases, 2020;14(3):e0007813.
[18] Zeng J, Xie X, Feng XL, et al. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice. EBioMedicine 2022;75:103803.